Gleason Group’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.34K | Hold |
4,206
| – | – | ﹤0.01% | 285 |
|
|
2026
Q1 | $7.02K | Hold |
4,206
| – | – | ﹤0.01% | 191 |
|
|
2025
Q4 | $6.5K | Hold |
4,206
| – | – | ﹤0.01% | 190 |
|
|
2025
Q3 | $4.96K | Hold |
4,206
| – | – | ﹤0.01% | 175 |
|
|
2025
Q2 | $3.55K | Buy |
4,206
+4,166
| +10,415% | +$7.12K | ﹤0.01% | 184 |
|
|
2025
Q1 | $126 | Sell |
40
-1
| -2% | -$5 | ﹤0.01% | 187 |
|
|
2024
Q4 | $274 | Hold |
41
| – | – | ﹤0.01% | 190 |
|
|
2024
Q3 | $500 | Hold |
41
| – | – | ﹤0.01% | 185 |
|
|
2024
Q2 | $923 | Hold |
41
| – | – | ﹤0.01% | 262 |
|
|
2024
Q1 | $2.02K | Hold |
41
| – | – | ﹤0.01% | 191 |
|
|
2023
Q4 | $3.09K | Hold |
41
| – | – | ﹤0.01% | 200 |
|
|
2023
Q3 | $3.4K | Hold |
41
| – | – | ﹤0.01% | 205 |
|
|
2023
Q2 | $5.64K | Hold |
41
| – | – | ﹤0.01% | 199 |
|
|
2023
Q1 | $11.7K | Hold |
41
| – | – | ﹤0.01% | 170 |
|
|
2022
Q4 | $10.6K | Hold |
41
| – | – | ﹤0.01% | 169 |
|
|
2022
Q3 | $11K | Hold |
41
| – | – | ﹤0.01% | 171 |
|
|
2022
Q2 | $14K | Hold |
41
| – | – | ﹤0.01% | 162 |
|
|
2022
Q1 | $25K | Buy |
+41
| New | +$22.7K | 0.01% | 143 |
|